1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

A Cautionary Tale for All Labs

Discussion in 'CSI Laboratories' started by Anonymous, Feb 28, 2013 at 3:06 PM.

  1. Anonymous

    Anonymous Guest

    This from the Bioreference site:

    Originally Posted by MY CHEMICAL ROADRACE
    http://thestreetsweeper.org/undersur...Shock_Therapy_

    WOW!!! Other labs on this site had better pay attention to this too. Pushing needless and more expensive testing is going to come back and bite them big time.
     
  2. Anonymous

    Anonymous Guest

    Re: STREETSWEEPER AT IT AGAIN.LOL

    --------------------------------------------------------------------------------
    Quote:
    Originally Posted by Anonymous
    Tell that to the 24 women in the U.S. who developed chancroid in 2010. Of course it's medically necessary to screen the entire female population of America for an organisim endemic to the developing nations of Africa, Asia, and Latin America.

    LOL. What I love is how different companies pump women full of fear about ordering tests like these. Make it look like these diseases are common or that they will harm them if they dont find it ASAP. I noticed one company really putting out the scare tactics about Trichomonas lately trying to make all women fear that they may have it and not know it. Oh my, what will they do?

    Lab industry and health care in general is a cesspool. Its a bubble that is imploding just like housing, dot.com and on and on.